FEASIBILITY AND SAFETY OF TRANSABDOMINAL CHORIONIC VILLUS SAMPLING
AbstractBackground: Chorionic Villus Sampling (CVS) is the technique of choice for prenatal diagnosis prior to12 weeks gestation. The objective of this study was to determine the feasibility, and pattern ofcomplications following first trimester Trans-abdominal Chorionic Villus Sampling (TA-CVS).Methods: This was a descriptive study conducted in the Obstetrics and Gynaecology DepartmentMilitary Hospital (MH) Rawalpindi from Jan 2007 to July 2008. Couples at risk of giving birth to a childwith genetic disorder were identified and counselled. Trans-abdominal Chorionic Villus Sampling wasdone using double needle technique under ultrasound guidance. Immediate and late complications werefollowed up. Data was analysed using SPPS-10. Results: On 200 cases chorionic villus sampling wasdone as an outdoor procedure. Most common indication was thalassaemia trait 75 (37.5%). Mostprocedures were done between 12–13 weeks. All placental positions including 104 (52%) posterior and71 (35.5%) anterior were approachable. Most aspirations were easy, however, in 30 (15%) the aspirationwas difficult. Overall success rate was 100%. In 158 (79%) of the cases sample yield was good. One(0.5%) patient had vaginal bleeding and three (1.5%) had placental haematoma formation. Most patients(84%) experienced mild pain during the procedure. The procedure related miscarriage occurred in 2(1%) patients while another patient developed this complication after 6 weeks. Conclusion: Firsttrimester TA-CVS is an accurate and safe invasive prenatal diagnostic procedure. Placentas in almostany position can be approached without any significant risk to mother and the foetus.Keywords Prenatal diagnosis, thalassaemia, chorionic sampling
Cederholm M, Haglund B, Axelsson O. Maternal complications
following amniocentesis and chorionic villus sampling for prenatal
karyotyping. BJOG 2003;110:392–9.
Silver RK, Wilson RD, Philip J, Thom EA, Zachary JM, Mohide
P. Late first trimester placental disruption and subsequent
gestational hypertension/preeclampsia. Obstet Gynecol
Lau KT, Leung YT, Fung YT, Chan LW, Sahota DS, Leung NT
et al. Outcome of 1,355 consecutive transabdominal chorionic
villus sampling in 1,351 patients. Chin Med J (Engl)
Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and
chorionic villus sampling for prenatal diagnosis (Cochrane
Review). Cochrane Database Syst Rev 2003;(3):CD003252.
Arora S, Kabra M, Maheshwari M, Shastri S, Kaur D, Deka D et
al. Prenatal diagnosis of haemoglobinopathies. Natl Med J India
Ahmed S, Saleem M, Sultana N, Raashid Y, Waqar A, Anwar M
et al. Prenatal Diagnosis of beta-thalassaemia in Pakistan:
experience in a Muslim Country. Prenat Diagn 2000;20:378–83.
Wapner RJ. Invasive Prenatal Diagnostic Techniques. Semin
Brambati B, Tului L, Camurri L, Guercilena S. Early second
trimester (13–20 weeks) transabdominal chorionic villus sampling
(TA-CVS): a safe and alternative method for both high and low
risk population. Prenat Diagn 2002;22:907–13.
Stetten G, Escallon CS, South ST. Reevaluating confined
placental mosaicism. Am J Med Genet A 2004;131:232–9.
Muzejinovic F, Alfirevic Z. Procedure–related complicationsof
amniocentesis and chorionic villus sampling: a systemic review.
Obstet Gynecol 2007;110:687–94.
Odibo AO, Dicke JM, Gray DL, Oberle M, Stamimio DM,
Macones GA, et al. Evaluating the rate and risk factors for foetal
loss after chorionic villus sampling. Obstet Gynecol
Aaron B. Caughey, AB, Linda M. Hopkins, Mary E. Norton ME.
Chorionic villus sampling compared with amniocentesis and the
difference in the rate of preganancy loss. Obstet Gynecol
Brun JL, Mangione R, Gangbo F, Guyon F, Taine L, Roux D.
Feasibility, accuracy and safety of chorionic villus sampling: a
report of 10741 cases. Prenat Diagn 2003;23:295–301.
Chorionic villus sampling and amniocentesis: recommendations
for prenatal counseling. Centers for Disease Control and
Prevention. MMWR Recomm Rep 1995;44(RR-9):1–12.
Ball RH. Invasive foetal testing Curr Opin Obstet Gynecol
Antsaklis A, Souka AP, Daskalak is G, Kavalakis Y, Michalas S.
Second trimester amniocentesis vs chorionic villus sampling for
prenatal diagnosis in multiple gestations. Ultrasound Obstet
Brambati B Tului L, Cislaghi C, Alberti E. First 10,000 chorionic
villus samplings performed on singleton pregnancies by a single
operator. Prenat Diagn 1998;18:255–66.
Medical Research Council European trial of chorionic villus
sampling. MRC working party on the evaluation of chorion villus
sampling. Lancet 1991;337:1491–9.
Jackon LG, Zachary JM, Fowler SE, Desnick RJ, Golbus MS,
Ledbetter DH, et al. A randomized comparison of transcervical
and transabdominal chorionic villus sampling. The U.S National
Institute of Child Health and Human Development Chorionicvillus sampling and Amniocentesis Study Group. N Engl J Med
Schaap AH, Van der Pol HG, Boer K, Leschot NJ, Wolf H. Long
term follow up of infants after transcervical chorionic villus
sampling and after amniocentesis to compare congenital
abnormalities and health status. Prenat Diagn 2002;22:598–604.
Cederholm M, haglund B, Axelsson O. Infant morbidity following
amniocentesis and chorionic villus sampling for prenatal
karyotyping. BJOG 2005;112:394–402.
Ejskjaer KV, Sorensen AU, Johannesen PL, Praest J.
Amnoicentesis and chorionic villi biopsy: A 10 year material.
Ugeskr Laeger 2001;163:4750–3.
Papp C, Beke A, Mezei G, Toth–Pal E, Papp Z. Chorionic villus
sampling: a 15 year experience. Foetal Diagn Ther 2002;17:218–27.
Brambati B, Tului L, Guercilena S. Alberti E. Outcome of first
trimester chorionic villus sampling for genetic investigation in
multiple pregnancy. Ultrasound Obstet Gynecol 2001;17:209–16.
J Ayub Med Coll Abbottabad 2012;24(1)
Denise M, Humphrey H, Godelieve M, Wilma E, Hans J, Sicco
A. Fetomaternal hemorrhage in relation to chorionic villus
sampling revisited. Prenat Diagn 2006;26: 201–5.
Eddleman KA, Stone JL, Lynch. L, Berkowitz RL, Chorionic
villus sampling before multi foetal pregnancy reduction. Am J
Obstet Gynecol 2000;183:1078–81.
Harris RA, Washington AE, Nease RF, Kuppermann M. Cost
utility of prenatal diagnosis and the risk based threshold. Lancet
Ahmed H, Sultana N. Indications and complications of chorionic
villus sampling. Pak Armed Forces Med J 2005;55(1):3–7.
Dolkart L, Harter M, Synder M. Four–Dimensional
ultrasonographic guidance for invasive obstetric procedures. J
Ultrasound Med 2005;24:1261–6.
Wax JR, Carpenter M, Chard R, Cartin A, Pinette MG. Pain
associated with transabdominal chorionic villus sampling:
Anticipated versus actual. J Matern Foetal Neonat Med
Baig SM, Azhar A, Hassan H, Baig JM, Aslam M, Ud Din MA, et
al. Prenatal Diagnosis of beta thalassaemia in southern Punjab,
Pakistan. Prenat Diagn 2006;26:903–5.
Samavat A, Model B. Iranian National thalassaemia screening
programme. BMJ 2004;329:1134–7.
Eisenberg B, Wapner RJ. Clinical procedures in prenatal
diagnosis. Best Pract Res Clin Obstet Gynaecol 2002;16:611–27.